Posted Apr. 26, 2013 at 5:36 a.m.

Premium Lock GSK drug partner Theravance to split into two ventures

Published: 2013-04-26 05:36:18
Updated: 2013-04-26 05:36:18

Print this blog post

Theravance formed a partnership with Glaxo a decade ago to develop respiratory treatments. Glaxo is the largest Theravance stakeholder with 27 percent of the company's shares....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa